Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
BUB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NME4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TIAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC102606465 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GEMIN6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLTP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ODF2L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR15A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC74B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHF19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBQLN4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NEDD4L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MTA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAP1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKS6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
THRB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR155 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FGF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on